Format
Items per page
Sort by

Send to:

Choose Destination

Links from

Items: 1 to 20 of 136

  • Showing results for a modified search because your search retrieved no results.
1.

Biliary excretion of etoposide in children with cancer.

Veal GJ, Errington J, Thomas HD, Boddy AV, Lowis S.

Cancer Chemother Pharmacol. 2006 Sep;58(3):415-7. Epub 2006 Jan 18.

PMID:
16418874
2.

Plasma etoposide catechol increases in pediatric patients undergoing multiple-day chemotherapy with etoposide.

Zheng N, Felix CA, Pang S, Boston R, Moate P, Scavuzzo J, Blair IA.

Clin Cancer Res. 2004 May 1;10(9):2977-85.

3.

Hepatic transport, metabolism and biliary excretion of irinotecan in a cancer patient with an external bile drain.

de Jong FA, Kitzen JJ, de Bruijn P, Verweij J, Loos WJ.

Cancer Biol Ther. 2006 Sep;5(9):1105-10. Epub 2006 Sep 19.

PMID:
16969123
4.

[Biliary and pancreatic excretion of etoposide].

Suda Y, Fujiki T.

Gan To Kagaku Ryoho. 1996 Aug;23(9):1191-6. Japanese.

PMID:
8751809
5.

Etoposide pharmacokinetics in children treated for acute myeloid leukemia.

Palle J, Frost BM, Gustafsson G, Hellebostad M, Kanerva J, Liliemark E, Schmiegelow K, Lönnerholm G; Nordic Society of Paediatric Haematology and Oncology.

Anticancer Drugs. 2006 Oct;17(9):1087-94. Erratum in: Anticancer Drugs. 2010 Jan;21(1):129. Britt-Marie, Frost [corrected to Frost, Britt-Marie]; Göran, Gustafsson [corrected to Gustafsson, Göran]; Marit, Hellebostad [corrected to Hellebostad, Marit]; Jukka, Kanerva [corrected to Kanerva, Jukka]; Eva, Liliemark [corrected to Liliemark, Eva]; Kjeld, Schmiegelow [corrected to Schmiegelow, Kjeld]; Gudmar, Lönnerholm [corrected to Lönnerholm, Gudmar].

PMID:
17001183
6.

Higher in vivo protein binding of etoposide in children compared with adult cancer patients.

Liliemark E, Söderhäll S, Sirzea F, Gruber A, Osby E, Björkholm M, Zhou R, Peterson C, Liliemark J.

Cancer Lett. 1996 Aug 23;106(1):97-100.

PMID:
8827052
7.

Crossover clinical study comparing the pharmacokinetics of etoposide (75 mg) administered as 25-mg capsules three times a day versus once a day.

Aydiner A, Koyuncu H, Tas F, Topuz E, Disci R.

Int J Clin Pharmacol Res. 2000;20(1-2):21-30.

PMID:
11146899
8.

Effect of cyclosporine A on the tissue distribution and pharmacokinetics of etoposide.

Cárcel-Trullols J, Torres-Molina F, Araico A, Saadeddin A, Peris JE.

Cancer Chemother Pharmacol. 2004 Aug;54(2):153-60. Epub 2004 Apr 27.

PMID:
15114410
9.

Feasibility of intraventricular administration of etoposide in patients with metastatic brain tumours.

Fleischhack G, Reif S, Hasan C, Jaehde U, Hettmer S, Bode U.

Br J Cancer. 2001 Jun 1;84(11):1453-9.

10.

The biliary excretion and pharmacokinetics of mezlocillin in jaundiced patients with external bile drainage.

Dooley JS, Gooding A, Hamilton-Miller JM, Brumfitt W, Sherlock S.

Liver. 1983 Aug;3(4):201-6.

PMID:
6672502
11.

Hepatobiliary kinetics and excretion of ciprofloxacin.

Parry MF, Smego DA, Digiovanni MA.

Antimicrob Agents Chemother. 1988 Jul;32(7):982-5.

12.

Population pharmacokinetics of high-dose etoposide in children receiving different conditioning regimens.

Würthwein G, Klingebiel T, Krümpelmann S, Metz M, Schwenker K, Kranz K, Lanvers C, Boos J.

Anticancer Drugs. 2002 Jan;13(1):101-10.

PMID:
11914647
13.

Etoposide pharmacokinetics in patients with normal and abnormal organ function.

Arbuck SG, Douglass HO, Crom WR, Goodwin P, Silk Y, Cooper C, Evans WE.

J Clin Oncol. 1986 Nov;4(11):1690-5.

PMID:
3772420
14.

Metabolism and excretion of etoposide in isolated, perfused rat liver models.

Hande K, Bennett R, Hamilton R, Grote T, Branch R.

Cancer Res. 1988 Oct 15;48(20):5692-5.

15.

Pharmacokinetics of etoposide in plasma and cerebrospinal fluid in the space left by tumor removal.

Morikawa N, Mori T, Kawashima H, Takeyama M, Hori S.

Ann Pharmacother. 1999 Jan;33(1):115-6. No abstract available.

PMID:
9972399
16.

Pharmacokinetic modulation of oral etoposide by ketoconazole in patients with advanced cancer.

Yong WP, Desai AA, Innocenti F, Ramirez J, Shepard D, Kobayashi K, House L, Fleming GF, Vogelzang NJ, Schilsky RL, Ratain MJ.

Cancer Chemother Pharmacol. 2007 Nov;60(6):811-9. Epub 2007 Feb 17.

PMID:
17308893
17.

Excretion pathways of amphotericin B.

Craven PC, Ludden TM, Drutz DJ, Rogers W, Haegele KA, Skrdlant HB.

J Infect Dis. 1979 Sep;140(3):329-41.

PMID:
501147
18.

[Piperacillin: pharmacokinetic studies on the biliary and renal excretion (author's transl)].

Baier R, Puppel H, Zelder O, Zehner R.

Arzneimittelforschung. 1981;31(5):857-61. German.

PMID:
6456008
19.

Impact of imatinib on the pharmacokinetics and in vivo efficacy of etoposide and/or ifosfamide.

Rezaï K, Lokiec F, Grandjean I, Weill S, de Cremoux P, Bordier V, Ekue R, Garcia M, Poupon MF, Decaudin D.

BMC Pharmacol. 2007 Oct 27;7:13.

20.

Biliary excretion of cefixime: assessment in patients provided with T-tube drainage.

Westphal JF, Jehl F, Schloegel M, Monteil H, Brogard JM.

Antimicrob Agents Chemother. 1993 Jul;37(7):1488-91.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk